Houston pharma co. to sell facility to MD Anderson Cancer Center
Houston-based Bellicum Pharmaceuticals Inc. (Nasdaq: BLCM), a clinical-stage biopharmaceutical company focused on cellular immunotherapies, is selling a local facility to the University of Texas M.D. Anderson Cancer Center.
M.D. Anderson will pay $15 …
Read More